Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02073903 · ClinicalTrials.gov registry record
The Use of Dual-handset Interpreter Phones in an Inpatient Setting to Improve Communication With Limited English Proficiency Patients at MSKCC
A clinical trial of Inpatients With Limited English Proficiency, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 40
- Enrollment target
- 1
- Study location
NCT02073903: Completed study of Inpatients With Limited English Proficiency, sponsored by Memorial Sloan Kettering Cancer Center.
NCT02073903 is a study of Inpatients With Limited English Proficiency that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 40 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02073903, a study of Inpatients With Limited English Proficiency, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to introduce new technology and interpreter practices in the inpatient setting at MSKCC. We plan to install dual handset phones at the bedsides of limited English proficiency (LEP) patients and to assess the impact on both patient and physician communication effectiveness with this technology.
Primary Outcome
with the dual handset phones assessed by the survey
Conditions Studied
Interventions
- BEHAVIORAL Patient Survey
- BEHAVIORAL Provider Survey
Study Locations (1)
New York
- Memorial Sloan Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2014-02-24 |
| Est. Completion | 2020-01-08 |
What the finished NCT02073903 record still lists
NCT02073903 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target.
The record links to 1 condition, with Inpatients With Limited English Proficiency appearing as the primary indexed condition, and to 2 interventions - of which Patient Survey is the first listed.
NCT02073903 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT02073903 about?
NCT02073903 is a clinical study titled "The Use of Dual-handset Interpreter Phones in an Inpatient Setting to Improve Communication With Limited English Proficiency Patients at MSKCC". The purpose of this study is to introduce new technology and interpreter practices in the inpatient setting at MSKCC. We plan to install dual handset phones at the bedsides of limited English proficiency (LEP) patients and to assess the impact on both patient and physician communication effectivenes...
What is the current status of trial NCT02073903?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2014-02-24. Estimated completion is 2020-01-08.
What conditions does trial NCT02073903 study?
This clinical trial studies the following conditions: Inpatients With Limited English Proficiency.
What interventions are being tested in trial NCT02073903?
The interventions under investigation include: Patient Survey (BEHAVIORAL), Provider Survey (BEHAVIORAL).
Who is sponsoring clinical trial NCT02073903?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02073903 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI